DerrickJ/others: DerrickJ - Same as you I am a non-holder but have been watching NSB for some time. I think that the outlined path does make a lot of sense for a company with VERY limited funds (which might along the way have to do a CR at still low pricing to get things done).
But IF - or hopefully WHEN they can prove this up as outlined by them in this presentation, it will for CERTAIN attract interest by Big Pharma companies. A long way to go.
Best of luck to all NSB holders/buyers.
wasa
Ann: Changes to Board, page-11
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.494M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 54000 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 179255 | 2 |
View Market Depth
| Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable